<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN" "JATS-archivearticle1-3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.3" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JPSIM</journal-id>
      <journal-title-group>
        <journal-title>Journal of Pakistan Society of Internal Medicine</journal-title>
        <abbrev-title>J Pak Soc Intern Med</abbrev-title>
      </journal-title-group>
      <issn publication-format="print">2709-8729</issn>
      <issn publication-format="electronic">2710-0804</issn>
      <publisher>
        <publisher-name>Pakistan Society of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.70302/jpsim.v4i1.2317</article-id>
      <article-id pub-id-type="publisher-id">jpsim.v4i1.2317</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Medical Guidelines</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Diagnosis, Monitoring and Management of Rheumatoid Arthritis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Shaukat</surname>
            <given-names>Aamir</given-names>
          </name>
          <email>dr_aamirfcps@yahoo.com</email>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ata-Ur-Rehman</surname>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <institution>Faisalabad Medical University, Faisalabad.</institution>
      </aff>
      <author-notes>
        <corresp id="cor1">*Correspondence: Aamir Shaukat (dr_aamirfcps@yahoo.com)</corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic" iso-8601-date="2023-02-13">
        <day>13</day>
        <month>02</month>
        <year>2023</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic">
        <year>2023</year>
      </pub-date>
      <volume>4</volume>
      <issue>1</issue>
      <fpage>77</fpage>
      <lpage>80</lpage>
      <history>
        <date date-type="received" iso-8601-date="2022-11-17">
          <day>17</day>
          <month>11</month>
          <year>2022</year>
        </date>
        <date date-type="accepted" iso-8601-date="2022-11-28">
          <day>28</day>
          <month>11</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2023 The Author(s)</copyright-statement>
        <copyright-year>2023</copyright-year>
        <copyright-holder>The Author(s)</copyright-holder>
        <ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v4i1.2317" content-type="text/html"/>
      <self-uri xlink:href="https://psimj.com/article/jpsim.v4i1.2317.pdf" content-type="application/pdf"/>
      <abstract>
        <p>Rheumatoid Arthritis (RA) is a major health problem that is affecting life quality and lot of healthcare resources are utilised in the treatment and management, especially in countries with low GDP such as Pakistan (1,2). Rheumatoid arthritis (RA) is a chronic immune mediated disease of unknown etiology that is affecting nearly 1% of the world population (3). The major features of this disease are swelling, pain and stiffness and if left untreaded leads to permanent joint damge resulting in high rates of morbidity and mortality. RA is associated with work loss leading to augmented financial problem, amplified psychological stress, depression and, ultimately leading to decreased quality of life (4).</p>
      </abstract>
    </article-meta>
  </front>
  <!-- <body> omitted: no manuscript (.docx) on file -->
  <back>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <mixed-citation>Akhter E, Bilal S, Kiani A, Haque U. Prevalence of arthritis in India and Pakistan: a review. Rheumatol Int. 2011;31:849-55.</mixed-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <mixed-citation>Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:131622.</mixed-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <mixed-citation>McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365, 2205–19.</mixed-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <mixed-citation>Filipovic I, Walker D, Forster F et al. Quantifying the economic burden of productivity loss in rheumatoid arthritis. Rheumatology (Oxford). 2011; 50, 1083–90.</mixed-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <mixed-citation>Naqvi AA, Hassali MA, Aftab MT, Shyum Naqvi SB, Zehra F, Ahmad R, et al. Development of Evidence-Based Disease Education Literature for Pakistani Rheumatoid Arthritis Patients. Diseases.2017;5:27.</mixed-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <mixed-citation>Lau CS, Chia F, Dans L, et al. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis. Int J Rheum Dis. 2019;22:357–375.</mixed-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <mixed-citation>Lau CS, Chia F, Harrison A, Hsieh T-Y, Jain R, Jung SM et al. APLAR rheumatoid arthritis treatment recommendations. Int J Rheum Dis. 2015;18: 685-713.</mixed-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <mixed-citation>Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum, 2010, vol. 62 (pg. 2569-81).</mixed-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <mixed-citation>Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 2016;68:1–26.</mixed-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <mixed-citation>Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762–84.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
